for developing targeted therapy for neurological consequences of COVID-19 using miRNAs, since
epigenetic changes
Sufianov, A.,
Beilerli, A.,
Begliarzade, S.,
Ilyasova, T.,
Kudriashov, V.,
Liang, Y.,
Beylerli, O. (2023) of cells,
epigenetic
modifications, apoptosis, as well as in complex control and pathogenesis of various
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) to play a significant role in regulating gene expression through
epigenetic and posttranscriptional
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) and
epigenetic disorders. MicroRNAs are currently considered one of the most promising prognostic and diagnostic
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) that are associated with cell senescence and involve a wide range of signaling pathways and their
epigenetic